×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Potential Upside For Cytek Biosciences, Inc. (NASDAQ:CTKB) Not Without Risk
Simply Wall Street
It's not a stretch to say that Cytek Biosciences, Inc.'s ( NASDAQ:CTKB ) price-to-sales (or "P/S") ratio of 3.6x right...
1 day ago
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
FREMONT, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company,...
5 days ago
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Acquired by Charles Schwab Investment Management Inc.
Defense World
Read Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Acquired by Charles Schwab Investment Management Inc. at Defense World.
3 days ago
Cytek Biosciences Reports First Quarter 2024 Financial Results
GlobeNewswire
FREMONT, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell...
1 month ago
Cytek Biosciences Inc (CTKB) Q1 2024 Earnings: Revenue Surges, Yet Net Loss Persists
Yahoo Finance
On May 8, 2024, Cytek Biosciences Inc (NASDAQ:CTKB) disclosed its financial outcomes for the first quarter of 2024 through its 8-K filing. The...
4 weeks ago
Principal Financial Group Inc. Sells 8123 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)
Defense World
Read Principal Financial Group Inc. Sells 8123 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) at Defense World.
6 days ago
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
GlobeNewswire
FREMONT, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Today Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company,...
2 weeks ago
Cytek Biosciences Inc (CTKB) Reports Robust Revenue Growth and Positive Net Income in Q4 2023
Yahoo Finance
Cytek Biosciences Inc (CTKB) Reports Robust Revenue Growth and Positive Net Income in Q4 2023 · Revenue Growth: Q4 revenue increased by 21% year...
3 months ago
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
GlobeNewswire
FREMONT, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company,...
2 months ago
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
GlobeNewswire
FREMONT, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Today Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that its 1-laser and 2-laser...
1 week ago